Mansjo M, Espinosa-Gongora C, Samanci I, Groenheit R, Werngren J
Antimicrob Agents Chemother. 2024; 69(2):e0094624.
PMID: 39692505
PMC: 11823602.
DOI: 10.1128/aac.00946-24.
Greif G, Coithino C, Bentancor M, Robello C
J Clin Tuberc Other Mycobact Dis. 2024; 37:100482.
PMID: 39497756
PMC: 11532306.
DOI: 10.1016/j.jctube.2024.100482.
Serajian M, Marini S, Alanko J, Noyes N, Prosperi M, Boucher C
Bioinformatics. 2024; 40(Suppl 1):i39-i47.
PMID: 38940175
PMC: 11211809.
DOI: 10.1093/bioinformatics/btae243.
Perez-Martinez D, Zenteno-Cuevas R
PLoS One. 2024; 19(6):e0295464.
PMID: 38917091
PMC: 11198749.
DOI: 10.1371/journal.pone.0295464.
Hurtado J, Bentancor M, Laserra P, Coitinho C, Greif G
Microorganisms. 2024; 12(5).
PMID: 38792828
PMC: 11123834.
DOI: 10.3390/microorganisms12050999.
GenoMycAnalyzer: a web-based tool for species and drug resistance prediction for Mycobacterium genomes.
Kim D, Shin J, Yoo I, Jo S, Chu J, Cho W
BMC Genomics. 2024; 25(1):387.
PMID: 38643090
PMC: 11031912.
DOI: 10.1186/s12864-024-10320-3.
Implementation of Whole Genome Sequencing of Tuberculosis Isolates in a Referral Center in Rome: Six Years' Experience in Characterizing Drug-Resistant TB and Disease Transmission.
Cannas A, Butera O, Mazzarelli A, Messina F, Vulcano A, Parracino M
Antibiotics (Basel). 2024; 13(2).
PMID: 38391520
PMC: 10885968.
DOI: 10.3390/antibiotics13020134.
TB-DROP: deep learning-based drug resistance prediction of Mycobacterium tuberculosis utilizing whole genome mutations.
Wang Y, Jiang Z, Liang P, Liu Z, Cai H, Sun Q
BMC Genomics. 2024; 25(1):167.
PMID: 38347478
PMC: 10860279.
DOI: 10.1186/s12864-024-10066-y.
A precision overview of genomic resistance screening in Ecuadorian isolates of Mycobacterium tuberculosis using web-based bioinformatics tools.
Morey-Leon G, Mejia-Ponce P, Granda Pardo J, Munoz-Mawyin K, Fernandez-Cadena J, Garcia-Moreira E
PLoS One. 2023; 18(12):e0294670.
PMID: 38051742
PMC: 10697571.
DOI: 10.1371/journal.pone.0294670.
Genomic Characterization of Drug-Resistant L2/Beijing Isolates from Astana, Kazakhstan.
Auganova D, Atavliyeva S, Amirgazin A, Akisheva A, Tsepke A, Tarlykov P
Antibiotics (Basel). 2023; 12(10).
PMID: 37887224
PMC: 10604462.
DOI: 10.3390/antibiotics12101523.
Advancing tuberculosis management: the role of predictive, preventive, and personalized medicine.
Dohal M, Porvaznik I, Solovic I, Mokry J
Front Microbiol. 2023; 14:1225438.
PMID: 37860132
PMC: 10582268.
DOI: 10.3389/fmicb.2023.1225438.
Whole-Genome Sequencing of Isolates from Diabetic and Non-Diabetic Patients with Pulmonary Tuberculosis.
Shankaregowda R, Allegretti Y, Sumana M, Rao M, Raphael E, Mahesh P
Microorganisms. 2023; 11(8).
PMID: 37630441
PMC: 10457832.
DOI: 10.3390/microorganisms11081881.
The Role of Next-Generation Sequencing (NGS) in the Management of Tuberculosis: Practical Review for Implementation in Routine.
Beviere M, Reissier S, Penven M, Dejoies L, Guerin F, Cattoir V
Pathogens. 2023; 12(8).
PMID: 37623938
PMC: 10459500.
DOI: 10.3390/pathogens12080978.
Drug resistance prediction for with reference graphs.
Hall M, Lima L, Coin L, Iqbal Z
Microb Genom. 2023; 9(8).
PMID: 37552534
PMC: 10483414.
DOI: 10.1099/mgen.0.001081.
Molecular epidemiology and transmission dynamics of multi-drug resistant tuberculosis strains using whole genome sequencing in the Amhara region, Ethiopia.
Shibabaw A, Gelaw B, Ghanem M, Legall N, Schooley A, Soehnlen M
BMC Genomics. 2023; 24(1):400.
PMID: 37460951
PMC: 10351181.
DOI: 10.1186/s12864-023-09502-2.
Large Deletion is the Characteristic of Pyrazinamide-Resistant belonging to the East Asian Lineage.
Kim N, Kim D, Chu J, Jung S
Infect Chemother. 2023; 55(2):247-256.
PMID: 37407242
PMC: 10323538.
DOI: 10.3947/ic.2023.0037.
Rapid Identification of Lineage and Drug Resistance in Clinical Samples of .
Comin J, Vinuelas J, Lafoz C, Cebollada A, Ibarz D, Iglesias M
Microorganisms. 2023; 11(6).
PMID: 37374968
PMC: 10303844.
DOI: 10.3390/microorganisms11061467.
Operationalising targeted next-generation sequencing for routine diagnosis of drug-resistant TB.
Iyer A, Ndlovu Z, Sharma J, Mansoor H, Bharati M, Kolan S
Public Health Action. 2023; 13(2):43-49.
PMID: 37359066
PMC: 10290261.
DOI: 10.5588/pha.22.0041.
Clinical utility of target-based next-generation sequencing for drug-resistant TB.
Mansoor H, Hirani N, Chavan V, Das M, Sharma J, Bharati M
Int J Tuberc Lung Dis. 2023; 27(1):41-48.
PMID: 36853141
PMC: 9879084.
DOI: 10.5588/ijtld.22.0138.
Whole-genome sequencing-based analyses of drug-resistant Mycobacterium tuberculosis from Taiwan.
Xiao Y, Liu K, Lin W, Chan T, Jou R
Sci Rep. 2023; 13(1):2540.
PMID: 36781938
PMC: 9925824.
DOI: 10.1038/s41598-023-29652-3.